Global  

Covid-19 coronavirus: Drug company to charge thousands for virus treatment

New Zealand Herald Monday, 29 June 2020 ()
Covid-19 coronavirus: Drug company to charge thousands for virus treatmentThe maker of a drug shown to shorten recovery time for severely ill Covid-19 patients says it will charge US$2340 ($3640) for a typical treatment course for people covered by government health programs in the United States and other...
0
shares
ShareTweetSavePostSend
 

Related videos from verified sources

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment [Video]

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now..

Credit: Wochit Entertainment     Duration: 00:35Published
A man spent eight days in hospital after catching COVID-19 from sharing drinks at a bar [Video]

A man spent eight days in hospital after catching COVID-19 from sharing drinks at a bar

A man spent eight days in hospital after catching COVID-19 from sharing drinks at a bar on a night out. Financial tech Jimmy Flores, 30, admitted he didn't take the deadly virus seriously while..

Credit: SWNS STUDIO     Duration: 00:33Published
Drug used to help fight severe COVID-19 cases used locally [Video]

Drug used to help fight severe COVID-19 cases used locally

A drug recently credited with saving the lives of COVID-19 patients is being used by local doctors.

Credit: NewsChannel 5 Nashville     Duration: 01:39Published

Related news from verified sources

CytoDyn releases video highlighting the science of how leronlimab works in immuno-oncology

CytoDyn Inc (OTCQB:CYDY) has released an animation video to show how its investigational new drug, leronlimab, works to support immuno-oncology, the development...
Proactive Investors

Naturally Splendid Enterprises updates on clinical trial application for Cavaltinib to treat coronavirus

Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCMKTS:NSPDF) has revealed that it is submitting further information to Health Canada as part of its fast-track...
Proactive Investors

Anger as US snaps up supplies of Gilead coronavirus treatment Remdesivir

Gilead Inc ((NASDAQ:GILD) has had almost all its global supplies of potential coronavirus treatment Remdesivir acquired by the US government. The US Department...
Proactive Investors


Tweets about this

willyv5

Willy Veloz RT @SDonziger: American taxpayers paid millions to develop an anti-COVID drug that the company Gilead is now selling for $3,000 per treatme… 4 minutes ago

wishiwasferris

James 🖕🏻 RT @GraceyRx: This is beyond ridiculous & shows the selfishness of America. The absurdity of patents when it comes to medicine too, other p… 57 minutes ago

GraceyRx

Gracey This is beyond ridiculous & shows the selfishness of America. The absurdity of patents when it comes to medicine to… https://t.co/EYJCuJHNth 1 hour ago

ARSBBS

Andrey.btc RT @Lukewearechange: Big Pharma company Gilead wins as the official treatment for coronavirus. Announces $3,120 Price Tag for treatment wit… 2 hours ago

Judy_Sebastian

Judy Sebastian RT @thetafferboy: Capitalism: More people will die because a potentially life-saving drug has a patent so it can't be manufactured by anyon… 3 hours ago

thetafferboy

Mark Williams-Cook = 🅼🅰🆁🅺 🅲🅾🅾🅺 Capitalism: More people will die because a potentially life-saving drug has a patent so it can't be manufactured by… https://t.co/CFUWUNMl6V 3 hours ago

ecodaren

rbodpr RT @kyodo_english: Japanese pharmaceutical firm Eisai Co. is set to start clinical trials in the United States of its experimental drug eri… 3 hours ago

jurylady5

gail simmons RT @CNN: Gilead Sciences, the company that makes the Covid-19 drug remdesivir, announced in an open letter that it has decided to set a pri… 4 hours ago